Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Apr 5, 2020
Date Accepted: Apr 19, 2020
Date Submitted to PubMed: Apr 20, 2020
COVID-19 mobile positioning surveillance and contact tracing, and patient privacy
ABSTRACT
Background:
The coronavirus disease pandemic is the biggest global economic and health challenge of the century. Its effect and impact are still evolving with deaths estimated to reach 40 million if not checked. One effective and complementary strategy to slow the spread and reduce the impact is to trace primary and secondary contacts using technology.
Objective:
The objective of this paper is to survey strategies for digital contact tracing for COVID-19 pandemic and to present how using mobile positioning data conforms with Nigeria’s data privacy regulations.
Methods:
We conducted an exploratory review of current measures for COVID-19 contact tracing globally. We then analyzed how countries are using mobile positioning data technology in handling the COVID 19 pandemic spread. We made recommendations for how Nigeria can adopt this approach in context of Nigeria’s Data protection Regulation (NDPR).
Results:
Despite the potentials, digital contact tracing always comes in conflict with patient data privacy regulations. We found that Nigeria’s response complies with the NDPR, and that it is possible to leverage telecommunications call detail registry (CDR) to complement current strategies within the NDPR regulation.
Conclusions:
Our study show that mobile position data contact tracing is important for epidemic control as long as it conforms to relevant data privacy regulation. Implementation guideline will limit data misuse.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.